Key result
Higher grades of nonalcoholic fatty liver disease and increased liver stiffness (>6.1 kPa) were significantly associated with the presence of symptomatic coronary heart disease.
Why the study?
NAFLD is associated with greater risk of CHD, but no NAFLD diagnostic parameter reliably indicates CHD comorbidity.
Does liver stiffness measured by shear-wave elastography predict the presence of coronary heart disease in symptomatic patients?
Cross-Sectional (n=120)
No
Does liver stiffness measured by shear-wave elastography predict the presence of coronary heart disease in symptomatic patients?
Effect estimate: AUC 0.798
p-value: p=<0.001
Higher degrees of liver stiffness measured by shear-wave elastography are significantly associated with the presence and severity of coronary heart disease in patients with NAFLD.
Liver stiffness and visceral fat thickness were associated with CHD in NAFLD; leaves open whether these measures aid CHD risk stratification.
BACKGROUND AND AIM: Accumulating clinical and epidemiologic evidence indicates that nonalcoholic fatty liver disease (NAFLD) is not only associated with liver-related morbidity and mortality, but also with a greater risk of coronary heart disease (CHD). However, there is currently no diagnostic parameter for NAFLD that has been determined to reliably indicate the presence of CHD as a co-morbidity. We evaluated the liver stiffness and visceral fat thickness of NAFLD patients ultrasonographically to explore the relationship between liver stiffness, visceral fat thickness, and CHD, aiming to find explore the relationship between the liver stiffness and CHD. METHODS: We enrolled 120 consecutive patients who had been initially diagnosed with CHD on the basis of their symptoms. All patients underwent coronary angiography or computed tomography angiography, and were classified into a CHD group and a non-CHD group on the basis of the results. All patients underwent liver ultrasonography, shear-wave elastography, and visceral fat thickness measurement. RESULTS: NAFLD and visceral fat thickness were significantly positively correlated with CHD and Gensini score (P<0.001). Multivariate regression showed that age, male, cholesterol, liver stiffness, and visceral fat thickness were determinants of CHD. Age, cholesterol, liver stiffness, and visceral fat thickness cut-off points for the prediction of CHD were above 50 years old [area under the curve (AUC): 0.678; sensitivity, 87%; specificity, 42.6%], >3.76 mmol/L (AUC: 0.687; sensitivity, 68.4%; specificity, 64.8%), >6.1 kPa (AUC: 0.798; sensitivity, 50%; specificity, 92.6%), and >7.41 cm (AUC: 0.694; sensitivity, 52.6%; specificity, 87%), respectively. Compared with the use of age, gender, and cholesterol (model 1), the addition of the liver stiffness cut-off to model 1 resulted in a stronger predictive value (P=0.005). CONCLUSIONS: High-grade NAFLD is more present in symptomatic CHD. The higher degree of liver stiffness in patients with NAFLD, the higher risk of CHD in these NAFLD patients.
No takes yet. Share an insight, caveat, or question.
Song et al. (2019) conducted a cross-sectional in Coronary heart disease and Nonalcoholic fatty liver disease (n=120). Liver stiffness and visceral fat thickness vs. Patients without confirmed CHD was evaluated on Presence of coronary heart disease (CHD) (AUC 0.798, p=<0.001). Higher grades of nonalcoholic fatty liver disease and increased liver stiffness (>6.1 kPa) were significantly associated with the presence of symptomatic coronary heart disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: